Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

119
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
119
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.4K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.9K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.9K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

60
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
60
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

41
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digitization of Historical Data from Somalia's Last Smallpox Outbreaks 1976-1977.

Scientific data·2026
Same author

"The best way we can stop suicides is by making lives worth living": a mixed-methods survey in the UK of perspectives on suicide prevention from the autism community.

EClinicalMedicine·2026
Same author

Correction: The Burr distribution as a model for the delay between key events in an individual's infection history.

PLoS computational biology·2026
Same author

Misinformation harms medicine.

Lancet (London, England)·2026
Same author

Study protocol for the Champaign-Urbana population study.

Frontiers in neuroimaging·2026
Same author

Professor Ian Hall's contribution to the Discussion of 'Some statistical aspects of the COVID-19 response' by Wood et al.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2026
Same journal

Spatio-temporal modeling of zoonotic cutaneous leishmaniasis (ZCL) in the Algerian steppe: Epidemiological insights and climatic associations.

Epidemics·2026
Same journal

Measuring the growth of infectious disease modelling publications and their impact on policymaking: A large language model-assisted bibliometric review.

Epidemics·2026
Same journal

Identifying memory mechanisms in Bayesian models of behavioural change during epidemics.

Epidemics·2026
Same journal

Mapping the landscape of individual-based models for respiratory pathogen transmission in the pandemic and post-pandemic era (2020-2024): A systematic review.

Epidemics·2026
Same journal

A stochastic meta-population model of Ebola virus disease transmission for informing public health decisions.

Epidemics·2026
Same journal

Modelling serological cross-reactivity to disentangle the dynamics of West Nile and Usutu viruses in an emerging area.

Epidemics·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.3K

A human time dose response model for Q fever.

Charles W Heppell1, Joseph R Egan2, Ian Hall1

  • 1Public Health England, Porton, Wiltshire SP4 0JG, United Kingdom.

Epidemics
|July 2, 2017
PubMed
Summary
This summary is machine-generated.

Coxiella burnetii, a bioterrorism threat, can infect humans with as few as 15 inhaled organisms. This study models infection, estimating an infectious dose and a 17.6-day incubation period for Q fever risk assessment.

Keywords:
BacteriaCoxiella burnetiiDepositionHypergeometricMacrophageMathematical model

More Related Videos

Applying Fluorescence Resonance Energy Transfer FRET to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing
10:29

Applying Fluorescence Resonance Energy Transfer FRET to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing

Published on: July 6, 2016

11.2K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Related Experiment Videos

Last Updated: Feb 27, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.3K
Applying Fluorescence Resonance Energy Transfer FRET to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing
10:29

Applying Fluorescence Resonance Energy Transfer FRET to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing

Published on: July 6, 2016

11.2K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biodefense

Background:

  • Coxiella burnetii is a bioterrorism threat agent.
  • It is classified by CDC and NIAID.

Purpose of the Study:

  • Establish a human time-dose response model for inhaled C. burnetii.
  • Estimate key infection properties like infectious dose and incubation period.
  • Provide a framework for risk assessments of C. burnetii exposures.

Main Methods:

  • Developed a human time-dose response model.
  • Propagated uncertainty throughout the model.
  • Utilized human study data from the 1950s.

Main Results:

  • The infectious dose for 50% probability of infection is approximately 15 organisms.
  • A single inhaled organism can infect 5% of the exposed population.
  • Derived a low-dose incubation period of 17.6 days and an extracellular doubling time of 0.5 days.

Conclusions:

  • The study provides a robust framework for C. burnetii risk assessment.
  • Quantified critical parameters for understanding Q fever infection dynamics.
  • Highlights the low infectious dose and potential for widespread infection.